Skip to main content
. 2023 Apr 20;19(4):e1010575. doi: 10.1371/journal.pgen.1010575

Fig 4. Potential opportunities for using molecular subclassification as a mechanism for treatment stratification.

Fig 4

This simplified oncoplot shows the distribution of BRAF and MAP2K1 alterations within the sample cohort, shown in context with the site of action of RAF and MEK in the MAPK pathway. The four categories of variants are annotated to show potential therapeutic strategies, based on extrapolation of data from human studies.